Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Topregel is a topical non-opioid analgesic formulation being developed by Achelios Therapeutics for the temporary relief of joint and muscle pain. It utilizes the company's proprietary Achetogel™ topical and transdermal drug delivery technology platform, which is designed to facilitate the rapid penetration of high concentrations of active drugs through the dermis directly to the target site. Positioned for the over-the-counter (OTC) market, Topregel is currently in preclinical development. The formulation is part of a broader pipeline of topical medications aimed at treating pain and inflammation by delivering large quantities of active non-steroidal anti-inflammatory drugs (NSAIDs) or other analgesics directly to the affected tissue while minimizing systemic exposure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Topregel.